Literature DB >> 25684123

Improved emergency myelopoiesis and survival in neonatal sepsis by caspase-1/11 ablation.

Lori F Gentile1, Angela L Cuenca, Alex G Cuenca, Dina C Nacionales, Ricardo Ungaro, Philip A Efron, Lyle L Moldawer, Shawn D Larson.   

Abstract

Over one million newborns die annually from sepsis with the highest mortality in premature and low-birthweight infants. The inflammasome plays a central role in the regulation of innate immunity and inflammation, and is presumed to be involved in protective immunity, in large part through the caspase-1-dependent activation of interleukin-1β (IL-1β) and IL-18. Studies in endotoxic shock, however, suggest that endogenous caspase-1 activity and the inflammasome contribute to mortality primarily by promoting excessive systemic inflammatory responses. We examined whether caspase-1 and the inflammasome also regulate neonatal inflammation, host protective immunity and myelopoiesis during polymicrobial sepsis. Neonatal (5-7 days) C57BL/6 and caspase-1/11(-/-) mice underwent a low-lethality caecal slurry model of intra-abdominal sepsis (LD25-45 ). Ablation of caspase-1/11, but not apoptosis-associated speck-like protein containing a CARD domain or nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3), improved neonatal survival following septic challenge compared with wild-type mice (P < 0·001), with decreased concentrations of inflammatory cytokines in the serum and peritoneum. Surprisingly, caspase-1/11(-/-) neonates also exhibited increased bone marrow and splenic haematopoietic stem cell expansion (P < 0·001), and increased concentrations of granulocyte and macrophage colony-stimulating factors in the peritoneum (P < 0·001) after sepsis. Ablation of caspase-1/11 signalling was also associated with increased recruitment of peritoneal macrophages and neutrophils (P < 0·001), increased phagocytosis by neutrophils (P = 0·003), and decreased bacterial colonization (P = 0·02) in the peritoneum. These findings suggest that endogenous caspase-1/11 activity, independent of the NLRP3 inflammasome, not only promotes the magnitude of the inflammatory response, but also suppresses protective immunity in the neonate, so contributing to innate immune dysfunction and poor survival in neonatal sepsis.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  caspase-1/11; emergency myelopoiesis; inflammation; mouse; neonates

Mesh:

Substances:

Year:  2015        PMID: 25684123      PMCID: PMC4427394          DOI: 10.1111/imm.12450

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

Review 1.  Innate immunity of the newborn: basic mechanisms and clinical correlates.

Authors:  Ofer Levy
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

Review 2.  Caspase-1-induced pyroptotic cell death.

Authors:  Edward A Miao; Jayant V Rajan; Alan Aderem
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

3.  Cecal ligation and puncture-induced impairment of innate immune function does not occur in the absence of caspase-1.

Authors:  E D Murphey
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

Review 4.  Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses.

Authors:  Akihisa Matsuda; Asha Jacob; Rongqian Wu; Monowar Aziz; Weng-Lang Yang; Takeshi Matsutani; Hideyuki Suzuki; Kiyonori Furukawa; Eiji Uchida; Ping Wang
Journal:  J Nippon Med Sch       Date:  2012       Impact factor: 0.920

5.  The epidemiology of severe sepsis in children in the United States.

Authors:  R Scott Watson; Joseph A Carcillo; Walter T Linde-Zwirble; Gilles Clermont; Jeffrey Lidicker; Derek C Angus
Journal:  Am J Respir Crit Care Med       Date:  2002-11-14       Impact factor: 21.405

Review 6.  Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation.

Authors:  Sanjeev Mariathasan; Denise M Monack
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

7.  Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18.

Authors:  Anasuya Sarkar; Mark W Hall; Matthew Exline; Judy Hart; Nina Knatz; Na Tosha Gatson; Mark D Wewers
Journal:  Am J Respir Crit Care Med       Date:  2006-08-14       Impact factor: 21.405

8.  Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling.

Authors:  Matthew J Delano; Kindra M Kelly-Scumpia; Terri C Thayer; Robert D Winfield; Philip O Scumpia; Alex G Cuenca; Phillips B Harrington; Kerri A O'Malley; Elizabeth Warner; Sonia Gabrilovich; Clayton E Mathews; Drake Laface; Paul G Heyworth; Reuben Ramphal; Robert M Strieter; Lyle L Moldawer; Philip A Efron
Journal:  J Immunol       Date:  2011-06-20       Impact factor: 5.422

9.  Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock.

Authors:  P Li; H Allen; S Banerjee; S Franklin; L Herzog; C Johnston; J McDowell; M Paskind; L Rodman; J Salfeld
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

10.  Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis.

Authors:  James L Wynn; Philip O Scumpia; Matthew J Delano; Kerri A O'Malley; Ricardo Ungaro; Amer Abouhamze; Lyle L Moldawer
Journal:  Shock       Date:  2007-12       Impact factor: 3.454

View more
  17 in total

Review 1.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 2.  Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis.

Authors:  Ben A Croker; John Silke; Motti Gerlic
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 3.  Newborn susceptibility to infection vs. disease depends on complex in vivo interactions of host and pathogen.

Authors:  Byron Brook; Danny Harbeson; Rym Ben-Othman; Dorothee Viemann; Tobias R Kollmann
Journal:  Semin Immunopathol       Date:  2017-11-02       Impact factor: 9.623

Review 4.  Pyroptosis-Induced Inflammation and Tissue Damage.

Authors:  Yinan Wei; Ling Yang; Ankit Pandeya; Jian Cui; Yan Zhang; Zhenyu Li
Journal:  J Mol Biol       Date:  2021-10-13       Impact factor: 5.469

Review 5.  The NLRP3 Inflammasome and Its Role in Sepsis Development.

Authors:  Lucinéia Gainski Danielski; Amanda Della Giustina; Sandra Bonfante; Tatiana Barichello; Fabricia Petronilho
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

6.  Adjuvant pretreatment with alum protects neonatal mice in sepsis through myeloid cell activation.

Authors:  J C Rincon; A L Cuenca; S L Raymond; B Mathias; D C Nacionales; R Ungaro; P A Efron; J L Wynn; L L Moldawer; S D Larson
Journal:  Clin Exp Immunol       Date:  2017-11-16       Impact factor: 4.330

7.  BCG vaccination-induced emergency granulopoiesis provides rapid protection from neonatal sepsis.

Authors:  Byron Brook; Danny J Harbeson; Casey P Shannon; Bing Cai; Daniel He; Rym Ben-Othman; Freddy Francis; Joe Huang; Natallia Varankovich; Aaron Liu; Winnie Bao; Morten Bjerregaard-Andersen; Frederik Schaltz-Buchholzer; Lilica Sanca; Christian N Golding; Kristina Lindberg Larsen; Ofer Levy; Beate Kampmann; Rusung Tan; Adrian Charles; James L Wynn; Frank Shann; Peter Aaby; Christine S Benn; Scott J Tebbutt; Tobias R Kollmann; Nelly Amenyogbe
Journal:  Sci Transl Med       Date:  2020-05-06       Impact factor: 17.956

8.  Cecal Slurry Injection in Neonatal and Adult Mice.

Authors:  Jaimar C Rincon; Philip A Efron; Lyle L Moldawer; Shawn D Larson
Journal:  Methods Mol Biol       Date:  2021

9.  Aluminum Adjuvant Improves Survival Via NLRP3 Inflammasome and Myeloid Non-Granulocytic Cells in a Murine Model of Neonatal Sepsis.

Authors:  Jaimar C Rincon; Russell B Hawkins; Mckenzie Hollen; Dina C Nacionales; Ricardo Ungaro; Philip A Efron; Lyle L Moldawer; Shawn D Larson
Journal:  Shock       Date:  2021-02-01       Impact factor: 3.533

Review 10.  NLRP3 inflammasome and its inhibitors: a review.

Authors:  Bo-Zong Shao; Zhe-Qi Xu; Bin-Ze Han; Ding-Feng Su; Chong Liu
Journal:  Front Pharmacol       Date:  2015-11-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.